MAKO Surgical Corp. (MAKO) Earnings: An Early Look – Johnson & Johnson (JNJ), Stryker Corporation (SYK)

Still, MAKO has favorable trends supporting its long-term prospects. Hip rivals Stryker Corporation (NYSE:SYK) and Johnson & Johnson (NYSE:JNJ) have both had to recall hip implants and face legal liability that could prove problematic for investors. In general, though, both companies have benefited greatly from their orthopedic divisions recently, with demographics supporting calls for increased numbers of procedures as baby boomers age and need more health care. MAKO is arguably a purer play on orthopedics specifically than J&J and has the higher reward of potential hypergrowth.

In its earnings report, it’ll be essential for MAKO to demonstrate a viable strategy for boosting sales at an accelerated pace. Otherwise, the risk that the high-growth stock will flame out will continue to hold investors back.

The article MAKO Surgical Earnings: An Early Look originally appeared on Fool.com and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Intuitive Surgical, Johnson & Johnson, and MAKO Surgical. The Motley Fool owns shares of Intuitive Surgical and Johnson & Johnson.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.